Shaers of Gilead Sciences, Inc. (NASDAQ:GILD) have been recommended as a long term growth pick according to Beta Research. With the firm’s stock price currently trading around $71.15, the firm has proven a solid track record of growth over the past few years. Investors might consider the stock as a long term growth candidate as the firm has yielded 41.20% earnings per share growth over the past 5 years and 29.40% revenue growth over that same time frame.
Let’s take a look at how the stock has been performing recently. Over the past twelve months, Gilead Sciences, Inc. (NASDAQ:GILD)’s stock was -0.64%. Over the last week of the month, it was -2.81%, -3.00% over the last quarter, and 10.29% for the past six months.
Over the past 50 days, Gilead Sciences, Inc.’s stock is -17.52% off of the high and -1.33% removed from the low. Their 52-Week High and Low are as follows: -17.52% (High), 11.59%, (Low).
Despite the past success, investors want to know where the stock is headed from here. Analysts covering the shares have a consensus short-term price target of $84.90 on the equity. Analysts have a consensus recommendation of 2.40 based on a 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.